Topic 8 - Applications of PCR: Detailed Study Guide

Topic 8: Learning Aims and Overview

  • Core Objectives:     * Explain the fundamental components of a Polymerase Chain Reaction (PCRPCR) reaction.     * Explain the three-step process of PCRPCR: denaturation, annealing, and extension (elongationelongation).     * Discuss medical applications of PCRPCR, specifically regarding diagnostics and screening.     * Discuss infectious disease applications of PCRPCR.     * Discuss forensic applications of PCRPCR, including genetic fingerprinting, Restriction Fragment Length Polymorphism (RFLPRFLP), Variable Number Tandem Repeat (VNTRVNTR), and Short Tandem Repeat (STRSTR).     * Discuss research applications of PCRPCR.

The PCR Process and Components

  • The Three Steps of PCR:     * 1. Denaturation: The double-stranded DNADNA template is heated to separate into two single strands.     * 2. Annealing: Temperature is lowered to allow primers to bind to their complementary sequences on the single-stranded DNADNA.     * 3. Elongation (Extension): TaqTaq polymerase adds nucleotides to the primers, synthesizing a new DNADNA strand.     * Cycle Progression: The sequence of steps (1,2, and 31, 2, \text{ and } 3) is repeated multiple times, leading to the exponential growth of the short target product.

  • Essential PCR Components:     * Template DNA: The original DNADNA molecule containing the target sequence to be amplified.     * Primers: Two short DNADNA sequences complementary to the 33' (threeprimethree prime) ends of each of the sense and anti-sense strands of the target DNADNA. Primers can be designed for any specific gene.     * dNTPs (Deoxynucleotide Triphosphates): The building blocks (A, T, C, G) used by the polymerase to synthesize new DNADNA.     * Taq Polymerase: A heat-stable DNADNA polymerase used to assemble the new DNADNA strands.     * Equipment: The reaction typically takes place in a Thermocycler (e.g., brands like Biometra).

Interpreting PCR and Gel Electrophoresis Results

  • Agarose Gel Electrophoresis:     * Used to visualize the results of PCRPCR amplification.     * Ladder/Molecular Weight Marker: Used to determine the size of the synthesized DNADNA bands. For example, a 122bp122\,bp band or a 1kb1\,kb ladder may be used for reference.     * Visualization: Gels are stained with Ethidium Bromide and photographed under UVUV light.     * Controls:         * Positive Control: Used to ensure the PCRPCR conditions were adequate for amplification.         * Negative Control: Used to ensure no contamination is present; no amplification should be observed.     * Example Analysis: In a test of three separate tissues using two primers, if Tissue #1 lacks a band while Tissue #2 and #3 possess it, it indicates the specific gene is not expressed or present in Tissue #1.

Medical Applications: Diagnostics and Screening

  • Genetic Disease Diagnostics:     * Examples: Hemophilia and Cystic Fibrosis.     * Mechanism: Primers are used to amplify only the mutated portion of a gene. If a product is created, the mutated gene is confirmed to be present.     * Cancer Related Genes: The HaloPlexTMHaloPlex^{TM} PCR BRCABRCA Panel Kit is used for efficient analysis of regions of interest in breast cancer susceptibility genes BRCA1BRCA1 and BRCA2BRCA2.

  • Genetic Screening Types:     * Prenatal Testing: Screening for genetic diseases offered to women during pregnancy.     * Newborn Screening: Carried out routinely in hospitals worldwide for conditions like Cystic Fibrosis.     * Carrier Screening: Used to determine if individuals carry a mutation that does not affect their health but could affect their future children (e.g., autosomal recessive inheritance).

  • Preimplantation Genetic Diagnosis (PGD):     * A technique to test embryos for specific genetic disorders before transfer during IVFIVF.     * Testing is typically performed at the Day 33, 686-8 cell stage of the embryo.     * This allows the selection of only unaffected embryos for transfer.

Case Study: Cystic Fibrosis (CF)

  • Overview: CFCF is characterized by thick, sticky mucus that blocks airways and pancreatic/bile ducts.
  • Genetic Basis: Caused by mutations in the CFTRCFTR gene located on Chromosome 77.
  • Cellular Mechanism:     * Normal CFTR Channel: Moves chloride (ClCl^-) ions to the outside of the cell.     * Abnormal CFTR Channel: Fails to move chloride ions, causing sticky mucus to build up outside the cell.
  • Newborn Screening Procedure:     1. Blood specimen collected on a card.     2. Punch a hole from the dried blood spot.     3. Proteinase K Digestion and lysis (using tools like ZRZR BashingBead Lysis Tube).     4. Purification steps: Bind, Wash, Elute.     5. Result: Ultra-pure DNADNA ready for PCRPCR.
  • Inheritance: Autosomal recessive. If both parents are carriers:     * 25%25\% chance the child is Normal.     * 50%50\% chance the child is a Carrier.     * 25%25\% chance the child has Cystic Fibrosis.

Infectious Disease Applications

  • Detected Pathogens: Tuberculosis (TBTB), HIVHIV, Gonorrhea, and Chlamydia.     * Chlamydia Detection: Chlamydia is a bacterial STDSTD. PCRPCR is preferred over Gram staining or culturing because of its sensitivity.     * Amplicon Size: For Chlamydia, a representative 2%2\% agarose gel might show a target amplicon band at 260bp260\,bp.

Forensic Applications and Genetic Variation

  • Polymorphism: The presence of genetic variation within a population, involving two or more variants of a DNADNA sequence.     * Single Base Pair Variation: The most common type of polymorphism.     * Nucleotide Diversity: Estimated to be 0.1%0.1\% to 0.4%0.4\% of base pairs in humans.     * Quantification: Approximately 33 million nucleotide differences in a human genome of approximately 33 billion nucleotides.

  • Evidence Techniques:     * RFLP (Restriction Fragment Length Polymorphism): Exploits variations in homologous DNADNA sequences at restriction enzyme sites. It requires a significantly larger blood sample compared to PCRPCR.     * VNTR (Variable Number Tandem Repeat): Short nucleotide sequences organized as tandem repeats. Variants act as inherited alleles used for parental or personal identification.     * STR (Short Tandem Repeat): Involves tracking the number of repeats at specific loci (e.g., Man 1 has 55 repeats, Man 2 has 66, Man 3 has 77).     * CODIS: Uses 1313 Core STRSTR Loci with specific chromosomal positions (e.g., TPOXTPOX, CSF1POCSF1PO, TH01TH01, vWAvWA, D3S1358D3S1358) for forensic matching.

  • Legal Case Studies:     * Colin Pitchfork (1988): The first conviction resulting from a mass DNADNA screen.     * OJ Simpson Trial: Blood samples matched OJOJ's genetic identity, but the defense alleged samples were tainted, mishandled, or switched ("The DNA Wars"), leading to a "not guilty" verdict.     * Exonerations: Illinois Governor George Ryan used DNADNA testing in 19981998 to exonerate 1313 of 2525 death row inmates. Roy Criner was exonerated by DNADNA testing for a rape and murder charge after initial judicial resistance.

Biological Complexities in DNA Evidence

  • Microchimerism: Women may carry at least three unique cell populations: their own, their mother's, and their child's.
  • Chimerism: An individual can effectively be their own twin. Lydia Fairchild was accused of fraud when maternity tests suggested she was not the mother of her own children; she was later found to be a chimera.

Research and Future Directions

  • Research Tools: Tools like Reverse Transcriptase (RTRT) are used to convert RNARNA into cDNAcDNA for PCRPCR amplification.
  • PCR vs. Sequencing:     * PCR: Looks at alleles, large masses of DNADNA, and STRSTR sizes resulting in bands.     * Sequencing: Identifies each individual letter of the DNADNA code.     * Trend: Whole Genome Sequencing (WGSWGS) costs are rapidly reducing, potentially shifting reliance away from traditional PCRPCR for some applications.

Paternity and Parental Testing

  • Procedure:     1. Treat DNADNA from Mother, Father, and Child with restriction endonucleases.     2. Separate fragments via gel electrophoresis.     3. Blot to nitrocellulose and probe with labeled DNADNA.     4. Prepare an autoradiogram to compare bands.
  • Logic: A child must receive one copy of every genetic marker/allele from each biological parent. Bands in the child's profile must be present in either the mother's or the father's profile.